Novo submits etavopivat, an investigational once-daily therapy for adolescents and adults living with sickle cell disease, to the FDA and EMA for approval

Novo and DJ Khaled team up to take fans behind the scenes of the iconic musician’s real-life “Walk, Golf, and Wegovy®” diet and weight-loss routine

Novo post hoc analysis finds Wegovy® 2.4 mg was associated with improvements in liver markers in adults with MASH with liver scarring and a BMI less than 27 kg/m², presented at The Liver Meeting® (AASLD) 2026